Unintended impact of pharmacovigilance regulatory interventions: A systematic review.

Lasys, Tomas; Santa-Ana-Tellez, Yared; Siiskonen, Satu J; Groenwold, Rolf H H; Gardarsdottir, Helga

Lasys, Tomas; Santa-Ana-Tellez, Yared; Siiskonen, Satu J; Groenwold, Rolf H H; Gardarsdottir, Helga.

Afiliación

Lasys T; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
Santa-Ana-Tellez Y; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
Siiskonen SJ; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.
Groenwold RHH; Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands.
Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.

Br J Clin Pharmacol ; 89(12): 3491-3502, 2023 12.

Article en En | MEDLINE | ID: mdl-37553757

Asunto(s)

Farmacovigilancia; Humanos; Europa (Continente); Análisis de Series de Tiempo Interrumpido

Palabras clave

impact evaluation; pharmacovigilance; postauthorization studies; real-world evidence; regulatory intervention; systematic literature review; unintended impact

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Farmacovigilancia Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Br J Clin Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google